Núñez, Olivier; Juaneda, Juan; Martínez-Marcos, Montserrat; Muñoz-Platón, Enriqueta; Rivas-Wagner, Eva; Santiago-Pérez, María-Isolina; Álvarez-Río, Virginia; Zornoza-Moreno, Matilde; Fernández-Ibáñez, Ana; Pérez-Suárez, Gisselle; Lorono-Ortiz, Gorka; Egues, Nerea; Berradre-Saenz, Belén; Cuesta-Franco, María-de-los-Ángeles; Casado-Cobo, Susana; Domínguez-Padilla, María; Castrillejo, Daniel; Mínguez-Santiyan, Ana; Basile, Luca; Rafael-de-la-Cruz-López, María-Ángeles; Sanabria-Curbelo, Diana; Pérez-Martínez, Olaia; Rodríguez-Recio, M-Jesús; Duró-Gómez, Lourdes; Alonso-Vigil, María-del-Pilar; Méndez-Díaz, Manuel-A; Sancho, Rosa; Castilla, Jesus; Ibáñez-Pérez, Ana-Carmen; Batalla-Rebollo, Noa; Sánchez-Piorno, Lucía; López-Berrios, Ninoska; Lamas, Joaquín; Olmedo, Carmen; Monge, Susana; Pastor-Barriuso, Roberto
(EUR CENTRE DIS PREVENTION & CONTROL, 2026-03-05)
BACKGROUNDIn autumn 2023, Spain recommended nirsevimab to all infants born after 1 April 2023, as catch-up or at-birth immunisation.AIMWe estimated effectiveness of a single nirsevimab dose against respiratory syncytial ...